Eversept Partners’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Eversept Partners’s Portfolio KRSA Stock Details KRSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,657	Closed	-$413K	–	84
2022 Q1	$413K	Hold	2,657	–	–	0.03%	82
2021 Q4	$640K	Hold	2,657	–	–	0.04%	96
2021 Q3	$1.14M	Buy	+2,657	New	+$174K	0.08%	94
2020 Q3	–	Sell	-1,769	Closed	-$1.46M	–	54
2020 Q2	$1.46M	Sell	1,769 -639	-27%	-$53.4K	0.2%	54
2020 Q1	$893K	Buy	+2,408	New	+$172K	0.22%	45
2019 Q3	–	Sell	-135	Closed	-$217K	–	60
2019 Q2	$217K	Buy	+135	New	+$38.2K	0.06%	61

Other funds holding KRSA

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TFS

TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Eversept Partners's KRSA Position: Q2 2022 in Review

Eversept Partners sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q2 2022, closing a stake of 2,657 shares — an estimated $413K sold.

Eversept Partners first reported a position in KRSA in Q2 2019 and held it in 6 quarters. The position peaked at $1.46M in Q2 2020. 36 funds tracked by Wall St. Rank hold KRSA as of Q2 2022.

Eversept Partners reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Eversept Partners sold 2,657 Korsana Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $413K.
Eversept Partners first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2019 and held it in 6 quarters.
Eversept Partners's Korsana Biosciences, Inc. Common Stock position peaked at $1.46M in Q2 2020.
36 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q2 2022.

Based on Eversept Partners's 13F filing for Q2 2022, filed 15 Aug 2022.